The Department of Transportation announced Friday another $636 million in funding that will be awarded to 49 applicants for ...

A list of organizations and entities offering relief for musicians and music industry professionals affected by the hugely ...

While legal experts say that marriage equality is likely safe for now, for many LGBTQ+ Americans — particularly in the South ...

The devastation of the fires in Los Angeles has been hard to fathom. Thousands have lost their homes, priceless personal ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

We have tips from California's insurance commissioner on how to contact the state and start the claims process, and how to ...

A non-profit that lost its tax-exempt status in 2020 represented itself as tax-exempt in its request for 2025 funding to the ...

HashKey MENA FZE, a member of HashKey Group, has received an In-Principle Approval (IPA) from the Dubai Virtual Assets ...

The U.S. Environmental Protection Agency (EPA) is officially taking comments on whether to issue new restrictions on the ...

Ardelyx currently expects full-year 2025 U.S. net product sales revenue for IBSRELA to be between $240.0 and $250.0 million. Ardelyx continues to expect IBSRELA to achieve greater than ten percent ...

Ex-CEO of MoviePass' parent company faces up to 25 years in prison © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December 2024 (Q4 2024).